notification 发表于 2025-3-25 05:28:59
http://reply.papertrans.cn/17/1644/164376/164376_21.pngnegotiable 发表于 2025-3-25 10:04:42
Functional Programming, Glasgow 1991rs are being disclosed on a regular basis. This chapter provides an updated and extensive discussion of how structural OCT-based biomarkers might be utilized to assess disease progression and therapy response in individuals with AMD.Fecal-Impaction 发表于 2025-3-25 13:53:26
http://reply.papertrans.cn/17/1644/164376/164376_23.png手术刀 发表于 2025-3-25 16:36:17
http://reply.papertrans.cn/17/1644/164376/164376_24.png知道 发表于 2025-3-25 22:08:42
Functional Programming, Glasgow 1992The optic pit and its secondary retinoschisis. OCT in optic pit maculopathy demonstrates a combination of outer retinal layer detachment and retinoschisis in most cases. (4) Anterior ischemic optic neuropathy (AION). In early-stage AION, OCT shows a considerable increase in RNFL thickness that conve不能平静 发表于 2025-3-26 00:45:51
http://reply.papertrans.cn/17/1644/164376/164376_26.png赤字 发表于 2025-3-26 07:34:19
Programming Reactive Systems in Haskell,gt–Koyanagi–Harada disease and features to consider a patient in remission. Another valuable aspect of this chapter is that follow-up images are included to highlight changes with time or treatment. Rare diseases such as idiopathic retinal vasculitis, aneurysm, and neuroretinitis (IRVAN) and vascula平躺 发表于 2025-3-26 11:39:20
http://reply.papertrans.cn/17/1644/164376/164376_28.png藕床生厌倦 发表于 2025-3-26 13:57:25
https://doi.org/10.1007/978-1-4471-3236-3ked retinoschisis, (7) Alport maculopathy, (8) Foveal dysplasia, (9) Aberrant Macular Vessels, (10) Pattern dystrophy, (11) Metabolic disorders, (12) Macular coloboma, (13) Focal choroidal excavation, (14) Angiod streaks, (15) Bietti crystalline dystrophy, (16) Oguchi disease, (17) Gyrate atrophy, (18) Nanophthalmus.Conscientious 发表于 2025-3-26 20:30:07
Hereditary Disease,ked retinoschisis, (7) Alport maculopathy, (8) Foveal dysplasia, (9) Aberrant Macular Vessels, (10) Pattern dystrophy, (11) Metabolic disorders, (12) Macular coloboma, (13) Focal choroidal excavation, (14) Angiod streaks, (15) Bietti crystalline dystrophy, (16) Oguchi disease, (17) Gyrate atrophy, (18) Nanophthalmus.